Literature DB >> 25954917

Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells.

Austin Huy Nguyen1, Ilya G Berim, Devendra K Agrawal.   

Abstract

Inflammation is tightly regulated by a vast system that is intricately interconnected with innate immunity. Aberrations in expression or signaling, such as in innate immune receptors, can create excessive inflammation and, when chronic, often promote oncogenesis. The triggering receptor expressed on myeloid cells receptor family has been characterized as a major player in the amplification and signaling of the inflammatory response. In a number of chronic inflammatory conditions and malignancies, the triggering receptor expressed on myeloid cells has been implicated in disease severity and progression. In this article, the current understanding of triggering receptor expressed on myeloid cells function in pre-malignant, malignant and chronic inflammatory conditions is critically reviewed. The potential for therapeutic application is also discussed.

Entities:  

Keywords:  TREM-1; TREM-2; chronic inflammation; colorectal cancer; hepatocellular carcinoma; inflammatory bowel disease; leukemia; neoplastic disease; non small cell lung cancer; triggering receptor expressed on myeloid cells

Mesh:

Substances:

Year:  2015        PMID: 25954917      PMCID: PMC4829915          DOI: 10.1586/1744666X.2015.1043893

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  68 in total

1.  Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.

Authors:  Yoon Suk Jung; Jae Jun Park; Seung Won Kim; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Dig Liver Dis       Date:  2012-06-19       Impact factor: 4.088

2.  Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.

Authors:  Michalis Tzivras; Vassilios Koussoulas; Evangelos J Giamarellos-Bourboulis; Dimitrios Tzivras; Thomas Tsaganos; Pantelis Koutoukas; Helen Giamarellou; Athanasios Archimandritis
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Cutting edge: TREM-2 attenuates macrophage activation.

Authors:  Isaiah R Turnbull; Susan Gilfillan; Marina Cella; Taiki Aoshi; Mark Miller; Laura Piccio; Maristela Hernandez; Marco Colonna
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

4.  Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients.

Authors:  I Wong-Baeza; N González-Roldán; E Ferat-Osorio; N Esquivel-Callejas; R Aduna-Vicente; L Arriaga-Pizano; H Astudillo-de la Vega; M A Villasis-Keever; R Torres-González; I Estrada-García; C López-Macías; A Isibasi
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

5.  Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1.

Authors:  Christine B Read; Joseph L Kuijper; Siv A Hjorth; Mark D Heipel; Xiaoting Tang; Andrew J Fleetwood; Jeffrey L Dantzler; Susanne N Grell; Jesper Kastrup; Camilla Wang; Cameron S Brandt; Anker J Hansen; Nicolai R Wagtmann; Wenfeng Xu; Vibeke W Stennicke
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 6.  HMGB1 and RAGE in inflammation and cancer.

Authors:  Gary P Sims; Daniel C Rowe; Svend T Rietdijk; Ronald Herbst; Anthony J Coyle
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

7.  TLR4 signaling pathway in mouse Lewis lung cancer cells promotes the expression of TGF-β1 and IL-10 and tumor cells migration.

Authors:  Chun Li; Haixia Li; Kun Jiang; Jing Li; Xiaodong Gai
Journal:  Biomed Mater Eng       Date:  2014       Impact factor: 1.300

8.  Alveolar macrophage recruitment and activation by chronic second hand smoke exposure in mice.

Authors:  Prescott G Woodruff; Almut Ellwanger; Margaret Solon; Christopher J Cambier; Kent E Pinkerton; Laura L Koth
Journal:  COPD       Date:  2009-04       Impact factor: 2.409

9.  Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study.

Authors:  Jie Zhang; Danyang She; Dan Feng; Yanhong Jia; Lixin Xie
Journal:  BMC Infect Dis       Date:  2011-03-01       Impact factor: 3.090

10.  TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria.

Authors:  Elsa-Noah N'Diaye; Catherine S Branda; Steven S Branda; Lisette Nevarez; Marco Colonna; Clifford Lowell; Jessica A Hamerman; William E Seaman
Journal:  J Cell Biol       Date:  2009-01-26       Impact factor: 10.539

View more
  18 in total

1.  Triggering Receptor Expressed on Myeloid Cells in Cutaneous Melanoma.

Authors:  Austin Huy Nguyen; Carleigh Koenck; Shannon K Quirk; Victoria M Lim; Mario V Mitkov; Ryan M Trowbridge; William J Hunter; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2015-07-16       Impact factor: 4.689

Review 2.  Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.

Authors:  Virginia Camacho; Victoria McClearn; Sweta Patel; Robert S Welner
Journal:  Int J Hematol       Date:  2017-02-07       Impact factor: 2.490

3.  Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors.

Authors:  Raffaella Fontana; Laura Raccosta; Lucrezia Rovati; Knut R Steffensen; Aida Paniccia; Tomas Jakobsson; Giulio Melloni; Alessandro Bandiera; Giorgia Mangili; Alice Bergamini; Daniela Maggioni; Claudio Doglioni; Roberto Crocchiolo; Marina Cella; Michela Mattioli; Cristina Battaglia; Marco Colonna; Vincenzo Russo
Journal:  Oncoimmunology       Date:  2018-12-13       Impact factor: 8.110

4.  Cutaneous expression of TREM, vitamin D receptor and HMGB1 in vitamin D deficiency.

Authors:  Austin H Nguyen; Victorial M Lim; Jonathan P Fleegel; William J Hunter; Devendra K Agrawal
Journal:  Int J Clin Exp Pathol       Date:  2016-08-15

5.  TREM-1 regulates neutrophil chemotaxis by promoting NOX-dependent superoxide production.

Authors:  Sankar Baruah; Shubha Murthy; Kathy Keck; Isabel Galvan; Allan Prichard; Lee-Ann H Allen; Mary Farrelly; Julia Klesney-Tait
Journal:  J Leukoc Biol       Date:  2019-01-22       Impact factor: 4.962

Review 6.  Triggering receptor expressed on myeloid cells in the pathogenesis of periodontitis: potential novel treatment strategies.

Authors:  Courtney P Rudick; Takanari Miyamoto; Melissa S Lang; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2017-10-20       Impact factor: 4.473

Review 7.  Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review.

Authors:  Austin Nguyen; Sheila Bhavsar; Erinn Riley; Gabriel Caponetti; Devendra Agrawal
Journal:  Int Arch Otorhinolaryngol       Date:  2016-04-19

Review 8.  Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review.

Authors:  Austin H Nguyen; Sheila B Bhavsar; Erinn M Riley; Gabriel C Caponetti; Devendra K Agrawal
Journal:  Contemp Oncol (Pozn)       Date:  2017-01-12

Review 9.  Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment.

Authors:  Jing Wang; Danyang Li; Huaixing Cang; Bo Guo
Journal:  Cancer Med       Date:  2019-06-20       Impact factor: 4.452

Review 10.  TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?

Authors:  Kouassi T Kouassi; Palanikumar Gunasekar; Devendra K Agrawal; Gopal P Jadhav
Journal:  J Cardiovasc Dev Dis       Date:  2018-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.